The suppressor mechanisms and their significance in tumor immunology S. M. MikulskiF. M. Muggia Short Review Pages: 139 - 142
The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells “educated” in vitro with MOPC-315 tumor cells Margalit B. MokyrD. P. BraunS. Dray Original Articles Pages: 143 - 150
In vitro induction of cell-mediated immunity to murine leukemia cells Eli KedarMaya SchwartzbachZiva Raanan Original Articles Pages: 151 - 159
In vitro induction of cell-mediated immunity to murine leukemia cells Eli KedarZiva RaananMaya Schwartzbach Original Articles Pages: 161 - 169
Evidence for the in vivo coating of a polyoma virus-induced tumor with antibodies specifically bound to their target-antigen Françoise RobertF. DumontD. Oth Original Articles Pages: 171 - 177
Adjuvant immunotherapy in acute nonlymphocytic leukemia Ch. S-n LindemalmA. KillanderB. Wadman Original Articles Pages: 179 - 183
Immunological effects of cancer chemotherapy in malignant melanoma Patricia M. ReynoldsRoger L. DawkinsMichael J. Byrne Original Articles Pages: 185 - 192
Further characterization of a non-T, non-B acute lymphoblastic leukaemia cell line (Reh) J. BertoglioC. GuiboutC. Rosenfeld Original Articles Pages: 193 - 196
Increased tritiated thymidine-labeling index of bone marrow myeloblasts following BCG administration in man M. RozencweigP. StryckmansMireille Socquet Original Articles Pages: 197 - 199
Pseudomonas vaccine: A phase I evaluation for cancer research G. N. HortobagyiJ. U. GuttermanE. M. Hersh Original Articles Pages: 201 - 207
Efficacy of BCG treatment after local radiotherapy in Lewis and MBL-2 tumor-bearing mice B. SerrouJ. B. DuboisL. Gauci Original Articles Pages: 209 - 214
